[Chirurgie des cancers de l'ovaire].

Rev Prat

AP-HP, centre Université Paris Cité, Hôpital européen Georges Pompidou, service de chirurgie cancérologique gynécologique et du sein, Paris, France - Université Paris Cité, INSERM UMR-S 1147 (médecine personnalisée, pharmacogénomique, optimisation thérapeutique), Paris, France.

Published: June 2022

OVARIAN CANCER SURGERY Surgery has a central role in the management of patients with epithelial ovarian cancer, and the quality of its implementation is a factor influencing the prognosis. For advanced stages, it is schematically based on two main steps: peritoneal cytoreductive surgery, and pelvic and para-aortic lymph node dissections. While the prognostic impact of reducing the peritoneal tumor burden has been well demonstrated (with the objective of no macroscopic residue at the end of the procedure), the prognostic impact of lymph node surgery is still debated in certain indications. Other questions are discussed, such as the place of surgery in the first-line therapeutic sequence (primary/upfront surgery or after neoadjuvant chemotherapy), the indication of intraperitoneal hyperthermic chemotherapy, or the role of surgery in recurrence situations.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ovarian cancer
8
lymph node
8
prognostic impact
8
surgery
7
[chirurgie des
4
des cancers
4
cancers l'ovaire]
4
l'ovaire] ovarian
4
cancer surgery
4
surgery surgery
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!